The Evaluation of Fatigue in Patients with Malignant Lymphoma Receiving Chemotherapy in Japan

DOI 機関リポジトリ HANDLE Web Site Web Site 参考文献17件

この論文をさがす

説明

<p>Background: Fatigue is the most common symptom in cancer patients, resulting from a variety of factors. About 80％ of cancer patients undergoing chemotherapy are believed to experience fatigue.</p><p>Objective: Levels of fatigue in patients with malignant lymphoma who received chemotherapy were evaluated.</p><p>Interventions/Methods: Participants were malignant lymphoma patients who received CHOP (R-CHOP) treatment or THP-COP (R-THP-COP) treatment. A fatigue questionnaire was given to evaluate patients’ levels of fatigue and weakness at the baseline and on the 4th, 8th and 12th days after chemotherapy.</p><p>Results: After treatment, the level of fatigue based on the Cancer Fatigue Scale (CFS) was the highest on the 8th day. The difference in the levels between the 8th day and the first day was significant (p<0.001).</p><p>Conclusions: The results suggest that the most marked physical fatigue was experienced on day 8 during each treatment period.</p><p>Implications for Nursing/Interpretation: It is important to focus more attention through nursing intervention research on circumstances involving patients’ feelings of fatigue during malignant lymphoma chemotherapy.</p>

収録刊行物

  • 北関東医学

    北関東医学 71 (3), 187-193, 2021-08-01

    北関東医学会

参考文献 (17)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ